Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.

Abstract

Hepatitis C virus (HCV) infection has become the most common indication for liver transplantation in the United States and Europe. Recurrence of HCV is universal in all liver graft recipients, but the natural history of the disease is variable with some patients displaying slowly progressive liver injury, while approximately 30% become cirrhotic within five… (More)
DOI: 10.1111/j.1399-0012.2011.01396.x

Topics

Cite this paper

@article{Cross2011NoninvasiveAO, title={Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.}, author={Timothy J S Cross and Dinesh Jothimani and Michael A. Heneghan and Phillip M. Harrison}, journal={Clinical transplantation}, year={2011}, volume={25 3}, pages={345-51} }